Scientific article
OA Policy
English

Response to statin therapy in obstructive sleep apnea syndrome: a multicenter randomized controlled trial

Published in

Mediators of inflammation, vol. 2014, 423120

Publication date

2014

Abstract

Accumulated evidence implicates sympathetic activation as inducing oxidative stress and systemic inflammation, which in turn lead to hypertension, endothelial dysfunction, and atherosclerosis in obstructive sleep apnea (OSA). Statins through their pleiotropic properties may modify inflammation, lipid profile, and cardiovascular outcomes in OSA.

Keywords

  • Adult
  • Aged
  • Atherosclerosis/drug therapy
  • Blood Pressure/drug effects
  • Cholesterol, LDL/metabolism
  • Double-Blind Method
  • Female
  • Heptanoic Acids/therapeutic use
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use
  • Male
  • Middle Aged
  • Pyrroles/therapeutic use
  • Sleep Apnea, Obstructive/drug therapy/metabolism

Citation (ISO format)

JOYEUX-FAURE, Marie et al. Response to statin therapy in obstructive sleep apnea syndrome: a multicenter randomized controlled trial. In: Mediators of inflammation, 2014, vol. 2014, p. 423120. doi: 10.1155/2014/423120

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

0962-9351
558views
450downloads

Technical informations

Creation

08/11/2015 10:23:00

First validation

08/11/2015 10:23:00

Update

14/03/2023 23:48:23

Status update

14/03/2023 23:48:23

Last indexation

31/10/2024 01:50:47
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated